CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
OPERATING ACTIVITIES
Net income including non-controlling interests	$ 15,242	$ 20,424
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation and amortization	4,181	4,016
Provision for doubtful accounts	3,390	3,638
Equity-based awards compensation expense	2,092	1,589
Loss on sale of business and sale or abandonment of assets, net	7,233	129
Deferred income tax	(543)	2,535
Other	(277)	(381)
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(3,318)	(1,298)
Increase in accounts receivable-other	(41)	(482)
Decrease in other assets	1,148	471
Decrease in accounts payable and accrued expenses	(899)	(1,709)
Increase in other liabilities	664	400
Net cash provided by operating activities	28,859	29,350
INVESTING ACTIVITIES
Purchase of fixed assets	(3,458)	(2,948)
Purchase of businesses, net of cash acquired	(10,128)	(7,402)
Acquisitions of non-controlling interests, net of sales	(1,668)	(1,314)
Net proceeds on sale of non controlling interest, fixed assets and business	448	297
Net cash used in investing activities	(14,806)	(11,367)
FINANCING ACTIVITIES
Distributions to non-controlling interests	(6,588)	(6,850)
Cash dividends to shareholders	(3,628)	(3,183)
Proceeds from revolving line of credit	88,450	55,900
Payments on revolving line of credit	(91,700)	(63,300)
Payment of notes payable	(459)	(284)
Excess tax benefit from stock options exercised	277	381
Other	47	53
Net cash used in financing activities	(13,601)	(17,283)
Net increase in cash	452	700
Cash-beginning of period	11,671	9,983
Cash-end of period	12,123	10,683
Cash paid during the period for:
Income taxes	4,402	5,200
Interest	352	538
Non-cash investing and financing transactions during the period:
Purchase of business-seller financing portion	$ 800	$ 350